Moreover, FGF19 treatment protected mice from CBDL-induced liver injury, whereas selective intestinal FXR overexpression decreased liver injury in the genetic Mdr2 knockout mouse model of cholestasis, confirming the importance of intestinal FXR for liver disease.91 Here, NR1H4 is linked to cholestasis.